Effect of conjugated linoleic acid, μ-calpain inhibitor, on pathogenesis of Alzheimer's disease
- 30 April 2013
- journal article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
- Vol. 1831 (4), 709-718
- https://doi.org/10.1016/j.bbalip.2012.12.003
Abstract
No abstract availableKeywords
Funding Information
- National Research Foundation of Korea
- Ministry of Education, Science and Technology (2011-0011007)
- Ewha Womans University
This publication has 61 references indexed in Scilit:
- GSK3: a key target for the development of novel treatments for type 2 diabetes mellitus and Alzheimer diseaseProgress in Neurobiology, 2011
- Calpain Activation Promotes BACE1 Expression, Amyloid Precursor Protein Processing, and Amyloid Plaque Formation in a Transgenic Mouse Model of Alzheimer DiseaseOnline Journal of Public Health Informatics, 2010
- Antiobesity mechanisms of action of conjugated linoleic acidThe Journal of Nutritional Biochemistry, 2010
- t10c12 Conjugated Linoleic Acid Suppresses HER2 Protein and Enhances Apoptosis in SKBr3 Breast Cancer Cells: Possible Role of COX2PLOS ONE, 2009
- Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer diseaseJCI Insight, 2008
- Involvement of Calpain Activation in Neurodegenerative ProcessesCNS Drug Reviews, 2006
- Tau Suppression in a Neurodegenerative Mouse Model Improves Memory FunctionScience, 2005
- RAGE and amyloid-β peptide neurotoxicity in Alzheimer's diseaseNature, 1996
- Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64dBiochemical and Biophysical Research Communications, 1989
- Efficient synthetic method for ethyl (+)-(2S,3S)-3-((S)-3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylate (EST), a new inhibitor of cysteine proteinases.CHEMICAL & PHARMACEUTICAL BULLETIN, 1987